DE69424731T2 - Antiulcerogenes Mittel und Adhäsionsinhibitor für Helicobacter pylori - Google Patents

Antiulcerogenes Mittel und Adhäsionsinhibitor für Helicobacter pylori

Info

Publication number
DE69424731T2
DE69424731T2 DE69424731T DE69424731T DE69424731T2 DE 69424731 T2 DE69424731 T2 DE 69424731T2 DE 69424731 T DE69424731 T DE 69424731T DE 69424731 T DE69424731 T DE 69424731T DE 69424731 T2 DE69424731 T2 DE 69424731T2
Authority
DE
Germany
Prior art keywords
agent
antiulcerogenic
adhesion inhibitor
helicobacter pylori
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69424731T
Other languages
English (en)
Other versions
DE69424731D1 (de
Inventor
Itsuko Kimura
Hideyuki Shibata
Masato Nagaoka
Shusuke Hashimoto
Haruji Sawada
Teruo Yokokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Publication of DE69424731D1 publication Critical patent/DE69424731D1/de
Application granted granted Critical
Publication of DE69424731T2 publication Critical patent/DE69424731T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/03Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/04Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/11Preparation or pretreatment of starting material involving culturing conditions, e.g. cultivation in the dark or under defined water stress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE69424731T 1993-09-24 1994-09-21 Antiulcerogenes Mittel und Adhäsionsinhibitor für Helicobacter pylori Expired - Lifetime DE69424731T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25888393 1993-09-24
JP11194694A JP3403496B2 (ja) 1993-09-24 1994-04-28 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤

Publications (2)

Publication Number Publication Date
DE69424731D1 DE69424731D1 (de) 2000-07-06
DE69424731T2 true DE69424731T2 (de) 2000-09-28

Family

ID=26451212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69424731T Expired - Lifetime DE69424731T2 (de) 1993-09-24 1994-09-21 Antiulcerogenes Mittel und Adhäsionsinhibitor für Helicobacter pylori

Country Status (10)

Country Link
EP (1) EP0645143B1 (de)
JP (1) JP3403496B2 (de)
KR (1) KR100296089B1 (de)
CN (1) CN1096867C (de)
AT (1) ATE193449T1 (de)
AU (1) AU7418794A (de)
CA (1) CA2132150C (de)
DE (1) DE69424731T2 (de)
NZ (1) NZ264517A (de)
TW (1) TW438593B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3916394B2 (ja) * 1996-01-26 2007-05-16 タカラバイオ株式会社 フコース硫酸含有多糖
CA2243543A1 (en) * 1996-01-26 1997-07-31 Research Institute For Glycotechnology Apoptosis inducers
EA002021B1 (ru) * 1996-06-12 2001-12-24 Такара Сузо Ко., Лтд. Фукоидансодержащие пищевые продукты, в частности, вызывающие апоптоз
US6573250B2 (en) 1996-06-12 2003-06-03 Takara Shuzo Co., Ltd. Food or beverage additive containing fucoidan and food and beverage containing fucoidan
JPH1070970A (ja) * 1996-07-01 1998-03-17 Nisshinbo Ind Inc モズク熱水抽出物及びその用途
AU719024B2 (en) * 1996-07-01 2000-05-04 Otsuka Pharmaceutical Factory, Inc. Hot-water extract of seaweed of the family spermatochnaceae and use thereof
JPH10191940A (ja) * 1997-01-16 1998-07-28 Yakult Honsha Co Ltd モズク抽出物の品質改良法およびモズク抽出物
JPH1135591A (ja) * 1997-07-18 1999-02-09 Masakuni Tako オキナワモズクから分離したフコイダンからのl−フコ ースの製造とそれの製造法
JPH1160590A (ja) 1997-08-22 1999-03-02 Yakult Honsha Co Ltd オリゴフコース誘導体又はオリゴラムノース誘導体及びその製造法
JPH11228602A (ja) * 1998-02-09 1999-08-24 Yakult Honsha Co Ltd 免疫力強化剤及び免疫力強化食品
WO1999041288A1 (fr) * 1998-02-17 1999-08-19 Takara Shuzo Co., Ltd. Saccharides sulfates
EP1002805A4 (de) * 1998-06-09 2003-01-29 Gen Corp Kk Bindungsinhibitore von helicobacter pylori
JP3982916B2 (ja) * 1998-07-31 2007-09-26 タカラバイオ株式会社 抗ヘリコバクター・ピロリ剤
DE69926770T2 (de) 1998-10-05 2006-06-29 Kabushiki Kaisha Yakult Honsha Antibakterielle mittel und ein herstellungsverfahren dafür
AU2007200916B2 (en) * 1998-10-05 2009-09-17 Kabushiki Kaisha Yakult Honsha Antibacterial agents and process for producing the same
CN1098707C (zh) * 1999-07-19 2003-01-15 齐清 含藻蛋白多糖提取物的药物组合物以及藻蛋白多糖的提取
AU6593400A (en) * 1999-08-20 2001-03-19 Takara Shuzo Co., Ltd. Remedies
US6812220B2 (en) 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
JP2003155244A (ja) * 2002-09-13 2003-05-27 Kyodo Milk Industry Co Ltd モズク由来のフコイダンを含む食品
JP2006143816A (ja) * 2004-11-17 2006-06-08 South Product:Kk 脱色フコイダンの製造方法
JP2006143817A (ja) * 2004-11-17 2006-06-08 South Product:Kk 脱色フコイダンの製造方法
CN100375755C (zh) * 2005-01-25 2008-03-19 上海中医药大学 一种长叶蜈蚣藻多糖提取物、其制备方法及用途
WO2007037249A1 (ja) 2005-09-27 2007-04-05 Asahi Kasei Chemicals Corporation セロオリゴ糖含有組成物
WO2008136397A1 (ja) * 2007-04-27 2008-11-13 Nisshin Pharma Inc. 消化性潰瘍を予防および/または治療するための組成物
CN101991598A (zh) * 2010-12-06 2011-03-30 吉林省辉南长龙生化药业股份有限公司 褐藻多糖硫酸酯在制备治疗胃肠疾病药物中的用途
JP2011241216A (ja) * 2011-05-23 2011-12-01 Kyodo Milk Industry Co Ltd モズク由来のフコイダンを含む食品
EP2692740A1 (de) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycanzusammensetzungen, Verfahren zu deren Herstellung und deren Verwendungen als Arzneimittel
JP6859017B2 (ja) * 2014-10-31 2021-04-14 第一産業株式会社 外用クリーム及びその製造方法
WO2017164411A1 (ja) * 2016-03-25 2017-09-28 株式会社クレイ沖縄 フコイダンともろみ酢とを混合した抗腫瘍方法又は物質
CN110731432A (zh) * 2019-11-18 2020-01-31 青岛锦慧盛源生物科技发展有限公司 一种海藻益生元护胃饮料及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792916A (fr) * 1971-12-16 1973-06-18 Hoechst Ag Medicament a activite antipeptique
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity

Also Published As

Publication number Publication date
AU7418794A (en) 1995-04-06
DE69424731D1 (de) 2000-07-06
CN1108572A (zh) 1995-09-20
KR950007868A (ko) 1995-04-15
KR100296089B1 (ko) 2001-10-24
CN1096867C (zh) 2002-12-25
EP0645143B1 (de) 2000-05-31
JP3403496B2 (ja) 2003-05-06
JPH07138166A (ja) 1995-05-30
CA2132150A1 (en) 1995-03-25
NZ264517A (en) 1995-12-21
CA2132150C (en) 2004-05-04
ATE193449T1 (de) 2000-06-15
EP0645143A1 (de) 1995-03-29
TW438593B (en) 2001-06-07

Similar Documents

Publication Publication Date Title
DE69424731T2 (de) Antiulcerogenes Mittel und Adhäsionsinhibitor für Helicobacter pylori
DK127688A (da) Farmaceutiske praeparater til anvendelse til behandling eller forebyggelse af sygdomme i mavetarmkanalen
BR9407720A (pt) Composto composiçao farmacêutica e processo para a prevençao ou tratamento de pertubaçoes imunorreguladoras ou doenças que compreendem a administraçao do composto
BR0010209A (pt) Composições para o tratamento de desordens do esÈfago
ZA864002B (en) Gamma-ifn as active substance for inhibiting(preventing)degradation processes in bone
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
DE69528602T2 (de) Prophylaktische behandlung der allergischen kontaktdermatitis
JPS5234935A (en) Medicinal composition
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
IL107153A (en) Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture
HUP9902054A1 (hu) Karbonát dihidratáz alkalmazása a makula ődéma kezelésére szolgáló gyógyszerkészítmények előállítására
GEP19970776B (en) Material for treating inflamation of gullet and inflamation and ulcer of gastric-bowels
BR9404781A (pt) Aplicação de moenomicina e/ou um ou mais de seus derivados; medicamento e processo para sua preparação; e processo para tratamento de úlceras gástricas
AU4726797A (en) Prophylactic/remedial agent
AU6580494A (en) Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
ES2103825T3 (es) Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.
ATE91415T1 (de) Phenoxy- und phenylthio-, amino-substituierte benzocyclo-alkan-derivate bei der behandlung und verhuetung von arzneimittelresistenten protozoen- infektionen.
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
GB2271509B (en) Antivenom immunesera
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
EP1002805A4 (de) Bindungsinhibitore von helicobacter pylori
WO2003095453A1 (fr) Composes a activite antihelicobacter
JPS5746920A (en) Drug for digestive tract
EP0539516A4 (de)
WO1999065511A3 (en) Composition and method for treatment of pseudomonas infection